Paul W. Maffuid

This profile gathers the share dealings of Paul W. Maffuid in Mabvax Therapeutics Holdings, Inc. Between 4 April 2016 and 2 April 2018, the trades on record add up to 20 filings.

On the open market, the record shows 3 purchases worth €4,499 and 11 sales worth €126k. The totals do not cover 2 filings with an undisclosed amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 2 share grants and 4 option exercises. 2018 to date brings no purchases and 4 sales.

The latest filing, published on 3 April 2018, reports an option exercise in Mabvax Therapeutics Holdings, Inc. The latest purchase dates back some time: it was published 3,366 days ago, on 2 August 2017. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.